Trasylol (aprotinin injection) Overview
February 15, 2006Trasylol is manyfactured by Bayer Pharmaceuticals and is designed for patients who undergo Cardiopulmonary Bypass (CPB) for Coronary Artery Bypass Graft (CABG) surgery. Trasylol has been linked to adverse events including stroke, encephalopathy, heart attack and kidney damage, and studies have shown that there are cheaper and safer generic options options available.
See the official Trasylol website and the FDA's Public Health Advisory about the drug for more complete information.
See your doctor if you have experienced serious side effects associated with Trasylol. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.